EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Epidemiology, Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs of Dedifferentiated Liposarcoma (DDLPS) in Canada: A Retrospective Cohort Study Using Administrative Databases in Ontario

Soo Jin Seung iD, Anisia Wong, Raymond Milan, Nisha Chandran, Albiruni R Abdul Razak

Current Oncology · 09.05.2025 · 32 (5) · 273

DOI: 10.3390/curroncol32050273 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Current Oncology, online erschienen am 09.05.2025. Verfasst von Soo Jin Seung und 4 weiteren Autor:innen. Beteiligte Einrichtung: HOPE Research Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada. Hauptthemen laut MEDLINE: Liposarcoma, Health Care Costs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Canada Ltd., Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dedifferentiated liposarcoma (DDLPS) is a rare, aggressive tumour with poor survival outcomes in advanced settings. This study assessed the incidence/prevalence, treatment patterns, survival, healthcare resource utilization (HCRU), and costs for DDLPS patients in Ontario, Canada.

Methods

A retrospective cohort study was conducted among DDLPS patients between 2010 and 2022 using administrative databases. Overall survival, all-cause HCRU, and costs (2023 Canadian dollars, CAD) were compared based on advanced disease and resection status.

Results

The overall incidence and cumulative prevalence of DDLPS was 0.465 and 1.995 per 100,000 people, respectively. Of all 611 DDLPS cases (64.3% male, median age [IQR]: 67 [57–76] years), 40.3% and 61.0% had advanced and unresected disease, respectively. The median overall survival (mOS) was 69 months [IQR = 15–151] for the entire cohort, but this was significantly lower for advanced and unresected disease (p < 0.0001). Among patients receiving systemic treatments (N = 117), 81.2% were prescribed doxorubicin as first-line treatment. All-cause healthcare costs (2023 CAD) amounted to CAD 34,448 per person-year (PPY), with inpatient hospitalizations being the highest cost driver at CAD 14,522 PPY and 0.8 inpatient hospitalization PPY for all years. Advanced disease had higher HCRU and costs.

Conclusions

This is the first comprehensive real-world evidence study that quantifies the high mortality and cost burden associated with DDLPS in Canada.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposarcomaHealth Care CostsHumansMaleFemaleRetrospective StudiesAgedOntarioMiddle AgedDatabases, FactualHealth Resources

Stichwörter der Autor:innen

costsdedifferentiated liposarcomahealthcare resource utilizationsurvivaltreatment patterns

Autor:innen und Institutionen

  • HOPE Research Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
  • Boehringer Ingelheim Canada Ltd., Burlington, ON L7L 5H4, Canada.
  • Toronto Sarcoma Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.

ORCID-Profile: Soo Jin Seung

Förderung

  • Boehringer Ingelheim Canada Ltd.
  • Boehringer Ingelheim

Zitieren

APA

Seung, S. J., Wong, A., Milan, R., Chandran, N., & Razak, A. R. A. (2025). Epidemiology, Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs of Dedifferentiated Liposarcoma (DDLPS) in Canada: A Retrospective Cohort Study Using Administrative Databases in Ontario. Current Oncology, 32(5), 273. https://doi.org/10.3390/curroncol32050273

Vancouver

Seung SJ, Wong A, Milan R, Chandran N, Razak ARA. Epidemiology, Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs of Dedifferentiated Liposarcoma (DDLPS) in Canada: A Retrospective Cohort Study Using Administrative Databases in Ontario. Current Oncology. 2025;32(5):273. doi:10.3390/curroncol32050273

BibTeX
@article{Seung2025,
  author = {Seung, Soo Jin and Wong, Anisia and Milan, Raymond and Chandran, Nisha and Razak, Albiruni R Abdul},
  title = {Epidemiology, Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs of Dedifferentiated Liposarcoma (DDLPS) in Canada: A Retrospective Cohort Study Using Administrative Databases in Ontario},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {5},
  pages = {273},
  doi = {10.3390/curroncol32050273}
}
Kostenlos starten →